Long-term Special Drug Use Investigation of Molidustat for Patients With Renal Anemia
Latest Information Update: 20 Aug 2024
At a glance
- Drugs Molidustat (Primary)
- Indications Anaemia
- Focus Adverse reactions
- Sponsors Bayer
- 14 Nov 2022 Planned End Date changed from 30 Sep 2026 to 30 Sep 2027.
- 14 Nov 2022 Planned primary completion date changed from 30 Jun 2026 to 30 Jun 2027.
- 13 Aug 2021 Status changed from not yet recruiting to recruiting.